Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Retraction Notice: Comprehensive Evaluation of Serum Microbiota and Metabolomic Profiles in Osteoporosis Patients Utilizing 16S rDNA Sequencing and UHPLC/MS Techniques

  • July 16, 2026

Share

  • 1

    The article titled 'Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients' has been retracted.

  • 2

    Concerns regarding the validity of the data were identified by the Frontiers Research Integrity Auditing team.

  • 3

    The authors did not provide raw data or satisfactory explanations during the investigation.

  • 4

    The Chief Editors of Frontiers in Medicine approved the retraction due to lack of confidence in the findings.

  • 5

    The authors have not responded to any correspondence regarding the retraction.

Original Source(s)

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

  • July 16, 2026

Related Content

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

Explainable machine learning for osteoporosis detection in patients with osteopenia: model development and validation using routine clinical data from an Asian cohort

Obesity and bone health: reconciling the density–fragility paradox